A decision to shift production for the U.S. market to factories in Serbia and Thailand, as well as a new factory under construction in South Carolina, has Chinese memory foam brand Mlily poised to boost the amount of product available in the U.S. market.

The strategic moves will enable Mlily and parent company Healthcare Co. Ltd. to service broader range of large and small retailers, all while holding the line on mattress prices.

“We knew the tariffs and duties would make products from our China factory more expensive and less competitive in the U.S., so we were able to move that production out of China to our two other factories rather quickly,” said James Ni, chairman and CEO of Healthcare Co. “Our South Carolina factory, which should be up and running by the end of this year, will eventually make the vast majority of Mlily products sold in the U.S and allow us to significantly grow our market share.”

The U.S. factory in Winnsboro, S.C., sits on 150 acres and will have a 650,000-square-foot main plant, employing an expected 250 employees in two shifts when it fully comes online later this year.

Currently, the plant is assembling mattresses whose components are coming mainly from its factories in Serbia and Thailand. The company’s 6-million-square-foot factory in Jiangsu, China, will focus on production for European and Asian markets.

“Moving our U.S. production out of China and eventually onto U.S. soil will give retailers the confidence that we can deliver our product on time and without major price fluctuations,” Ni said.

Mlily USA is the North American mattress and pillow company of Rugao, China-based Healthcare Co.